CIBC Sees Strength in QLT Inc.

Analyst says fresh data from the drug-maker's new vision therapy could triple the market for the drug

CIBC World reiterated its strong buy rating on QLT Inc. (QLTI ) shares.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.